Literature DB >> 31970585

Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing's syndrome.

Luigi Di Filippo1, Giordano Vitali1, Gianluca Taccagni2, Federica Pedica2, Giulia Guaschino3, Emanuele Bosi1,4, Sabina Martinenghi5,6.   

Abstract

Neuroendocrine carcinomas of the cervix are very rare, accounting for only 1-2% of all cervical cancers and <1% of all neuroendocrine tumors. Small-cell carcinoma of the cervix is associated with poor prognosis, even in early stages. Despite their neuroendocrine origin, tumors presenting with syndromes due to secreted neuroendocrine hormones are extremely rare. To date, only seven cases of cervical small-cell carcinoma associated with Cushing's syndrome due to ectopic ACTH secretion have been described. In most reports, Cushing's syndrome associated with these tumors occurred only in association with liver or lung metastasis. Only one single case of primary uterine cervix carcinoma secreting enough ACTH to induce Cushing's syndrome in the absence of metastatic disease has been described in 1994. Here, we describe a case of cervical small-cell carcinoma presenting with an acute onset of severe hypokalemia in Cushing's syndrome without metastatic disease to distant organs.

Entities:  

Keywords:  ACTH; Cervix carcinoma; Cushing’s syndrome; Hypokalemia; Neuroendocrine tumor

Mesh:

Substances:

Year:  2020        PMID: 31970585     DOI: 10.1007/s12020-020-02202-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  9 in total

Review 1.  Aberrant hormone activity by tumors of gynecologic importance.

Authors:  J M Shane; F Naftolin
Journal:  Am J Obstet Gynecol       Date:  1975-01-01       Impact factor: 8.661

2.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Authors:  Andrea M Isidori; Gregory A Kaltsas; Carlotta Pozza; Vanni Frajese; John Newell-Price; Rodney H Reznek; Paul J Jenkins; John P Monson; Ashley B Grossman; G Michael Besser
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

Review 3.  A case of small cell carcinoma of the uterine cervix presenting Cushing's syndrome.

Authors:  A Hashi; T Yasumizu; I Yoda; T Kou; K Mizuno; S Hirata; J Kato; R Katoh; M Inoue; A Kawaguchi; M Nakazato; T Onaya
Journal:  Gynecol Oncol       Date:  1996-06       Impact factor: 5.482

Review 4.  Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients.

Authors:  Joshua G Cohen; Daniel S Kapp; Jacob Y Shin; Renata Urban; Alexander E Sherman; Lee-may Chen; Kathryn Osann; John K Chan
Journal:  Am J Obstet Gynecol       Date:  2010-07-01       Impact factor: 8.661

Review 5.  Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.

Authors:  Angiolo Gadducci; Silvestro Carinelli; Giovanni Aletti
Journal:  Gynecol Oncol       Date:  2017-01-03       Impact factor: 5.482

6.  Cushing's syndrome due to ectopic corticotropin secretion: twenty years' experience at the National Institutes of Health.

Authors:  Ioannis Ilias; David J Torpy; Karel Pacak; Nancy Mullen; Robert A Wesley; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2005-05-24       Impact factor: 5.958

7.  Small cell carcinoma of the uterine cervix showing Cushing's syndrome caused by ectopic adrenocorticotropin hormone production.

Authors:  K Iemura; T Sonoda; A Hayakawa; S Abe; N Nemoto; I Adachi; H Tsuda; S Teshima
Journal:  Jpn J Clin Oncol       Date:  1991-08       Impact factor: 3.019

8.  Small cell carcinoma of the cervix: analysis of clinical and pathological findings.

Authors:  P H Wang; Y C Liu; C R Lai; H T Chao; C C Yuan; K J Yu
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

9.  Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.

Authors:  Akila N Viswanathan; Michael T Deavers; Anuja Jhingran; Pedro T Ramirez; Charles Levenback; Patricia J Eifel
Journal:  Gynecol Oncol       Date:  2004-04       Impact factor: 5.482

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.